Thyroid Medication and Antidepressants for Treating Major Depression
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of treatment with supplemental triiodothyronine
(T3, Cytomel) and sertraline (Zoloft), a selective serotonin reuptake inhibitor (SSRI), in
improving symptoms of major depressive disorder (MDD).